|
WO2005009346A2
|
|
Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo
|
|
WO2005116045A1
|
|
Compositions and processes using sirna, amphipathic compounds and polycations
|
|
WO2005060746A1
|
|
Delivery of viral vectors to extravascular parenchymal cells
|
|
WO2004067555A2
|
|
Protein and peptide delivery to mammalian cells in vitro
|
|
WO2005016355A1
|
|
Intravascular delivery of non-viral nucleic acid
|
|
WO2005009476A1
|
|
Intravascular delivery of non-viral nucleic acid
|
|
WO2004013307A2
|
|
Compounds for targeting hepatocytes
|
|
WO2004011060A2
|
|
Delivery of molecules and complexes to mammalian cells in vivo
|
|
WO2005004879A1
|
|
Intravascular delivery of non-viral nucleic acid
|
|
WO03106636A2
|
|
Novel methods for the delivery of polynucleotides to cells
|
|
WO03099225A2
|
|
Compositions for delivering nucleic acids to cells
|
|
WO2004020577A2
|
|
Processes for inhibiting gene expression using polynucleotides
|
|
WO2004076674A1
|
|
Delivery of sirna to cells using polyampholytes
|
|
WO2004070052A2
|
|
Compounds and processes for single-pot attachment of a label to nucleic acid
|
|
WO2004067776A1
|
|
COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO siRNA
|
|
WO2004062694A1
|
|
Devices and processes for distribution of genetic material to mammalian limb
|
|
WO2004065587A1
|
|
Compositions and processes using sirna, amphipathic compounds and polycations
|
|
WO2004062368A1
|
|
Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene.
|
|
EP1599230A1
|
|
Process for generating multilayered particles
|
|
US6740336B2
|
|
Process for generating multilayered particles
|
